Abstract
Primary Immunodeficiencies (PID) represent a group of heterogeneous immune diseases with important biological significance. We reviewed the records of children diagnosed with PID in the Referral Center for PID in our country in order to describe the epidemiological, clinical and laboratory characteristics of immunodeficient patients. During a 30-year period, 147 patients (101 males, 68.7 %), with a mean age of 6.5 years at the time of diagnosis, were diagnosed with PID. The most prevalent diagnoses of PID were: “Combined Immunodeficiency” in 46 (31.3 %) patients, “Well-defined immunodeficiency syndrome” in 35 (23.1 %) patients, “Predominantly antibody deficiency” in 30 (20.4 %) patients and “Congenital defect of phagocyte function or both” in 28 (19 %) patients. There was a higher prevalence of males with “Combined immunodeficiency” (p < 0.033) and “Predominantly antibody deficiency” (p < 0.02) compared to females. The median age of children at the onset of symptoms and at the time of diagnosis was 0.5y (IQR: 0.1–2.5) and 2y (IQR: 0.6–7.2), respectively. The median diagnostic delay was 0.9y (IQR: 0.2–4.8). This period was shorter for patients with “Combined immunodeficiency” [median 0.3y (IQR: 0.1–1)], and longer for those with “Predominantly antibody deficiency” [median 3.2y (IQR: 0.2–5.9) or “Disease of immune dysregulation” [median 3.2y (IQR: 0.1–6.6)]. Comparing the rates in our population with those of the European Registry (ESID), the rates of “Combined immunodeficiencies”, “Well-defined syndromes” and “Congenital birth defects and/or function of phagocytes” were significantly higher in this study (p <0,001). PID registry analysis improves knowledge in the field of Immunology and enhances awareness, early detection, diagnosis, and management of this rare but significant group of diseases.
Similar content being viewed by others
Abbreviations
- ALPS:
-
Autoimmune Lymphoproliferative Syndrome
- APECED:
-
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy
- CGD:
-
Chronic Granulomatous Disease
- CVID:
-
Common Variable Immunodeficiency
- ESID:
-
European Society for Immunodeficiencies
- HIES:
-
Hyper IgE Syndrome
- IFN-γR1:
-
Interferon-γ Receptor 1
- IUIS:
-
International Union of Immunological Societies
- MHC:
-
Major Histocompatibility Complex
- NOMID:
-
Neonatal Onset Multisystem Inflammatory Disease
- CINCA:
-
Chronic Infantile Neurological Cutaneous Articular
- PID/PIDs:
-
Primary Immunodeficiencies
- SCID:
-
Severe combined immunodeficiency
- WAS:
-
Wiskott-Aldrich Syndrome
- XHIMS:
-
X-linked Hyper-IgM Syndrome
- XLA:
-
X-linked agammaglobulinemia
References
Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94(5):S1–63.
de Vries E. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012;167(1):108–19.
Cassimos DC, Liatsis M, Stogiannidou A, Kanariou MG. Children with frequent infections: a proposal for a stepwise assessment and investigation of the immune system. Pediatr Allergy Immunol. 2010;21(3):463–73.
Griffith LM, Cowan MJ, Notarangelo LD, Puck JM, Buckley RH, Candotti F. Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. J Allergy Clin Immunol. 2009;124(6):1152–60. e12.
Chapel H. Classification of primary immunodeficiency diseases by the international union of immunological societies (IUIS) expert committee on primary immunodeficiency 2011. Clin Exp Immunol. 2012;168(1):58–9.
Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2011;2:54.
Sanal O, Tezcan I. Thirty years of primary immunodeficiencies in Turkey. Ann N Y Acad Sci. 2011;1238:15–23.
Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI)–diagnosis, treatment, and economic impact: an updated report from the Jeffrey modell foundation. Immunol Res. 2011;51(1):61–70.
Matamoros Flori N, Mila Llambi J, Espanol Boren T, Raga Borja S, Fontan CG. Primary immunodeficiency syndrome in Spain: first report of the national registry in children and adults. J Clin Immunol. 1997;17(4):333–9.
Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL et al. Primary Immunodeficiency Diseases Worldwide: More Common than Generally Thought. Journal of clinical immunology. 2012.
Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, et al. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013;173(2):372–80.
Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497–502.
Golan H, Dalal I, Garty BZ, Schlesinger M, Levy J, Handzel Z, et al. The incidence of primary immunodeficiency syndromes in Israel. The Israel Medical Association journal : IMAJ. 2002;4(11):868–71.
group CTFPs. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135(2):264–72.
Gathmann B, Binder N, Ehl S, Kindle G. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012;167(3):479–91.
Samarghitean C, Valiaho J, Vihinen M. Online registry of genetic and clinical immunodeficiency diagnostic laboratories, IDdiagnostics. J Clin Immunol. 2004;24(1):53–61.
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol. 2013;33(6):1078–87.
Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American group for immunodeficiency) and ESID (European society for immunodeficiencies). Clin Immunol. 1999;93(3):190–7.
Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29(3):343–51.
Kilic S, Ozel M, Hafizoglu D, Karaca N, Aksu G, Kutukculer N. The prevalences [correction] and patient characteristics of primary immunodeficiency diseases in Turkey–two centers study. J Clin Immunol. 2013;33(1):74–83.
Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait national primary Immunodeficiency Registry (2004–2006). J Clin Immunol. 2008;28(2):186–93.
Michos A, Tzanoudaki M, Villa A, Giliani S, Chrousos G, Kanariou M. Severe combined immunodeficiency in Greek children over a 20-year period: rarity of gammac-chain deficiency (X-linked) type. J Clin Immunol. 2011;31(5):778–83.
Raptaki MV, Spanou I, Tzanoudaki K, Tantou M, Liatsis S, Constantinidou M, et al. A 25-year Patient Registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece journal of clinical immunology. J Clin Immunol. 2013;33(8):1302–9.
Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr. 1997;130(3):378–87.
Yee A, De Ravin SS, Elliott E, Ziegler JB. Severe combined immunodeficiency: a national surveillance study. Pediatr Allergy Immunol. 2008;19(4):298–302.
Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clinic proceedings Mayo Clinic. 2009;84(1):16–22.
Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the republic of Ireland: first report of the national registry in children and adults. J Clin Immunol. 2005;25(1):73–7.
Stray-Pedersen A, Abrahamsen TG, Froland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol. 2000;20(6):477–85.
Eades-Perner AM, Gathmann B, Knerr V, Guzman D, Veit D, Kindle G, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol. 2007;147(2):306–12.
Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77–85.
Casanova JL, Fieschi C, Zhang SY, Abel L. Revisiting human primary immunodeficiencies. J Intern Med. 2008;264(2):115–27.
Grunebaum E, Mazzolari E, Porta F, Dallera D, Atkinson A, Reid B, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA. 2006;295(5):508–18.
Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Gene therapy of primary T cell immunodeficiencies. Gene. 2013;525(2):170–3.
Gungor T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet. 2014;383(9915):436–48.
Mukherjee S, Thrasher AJ. Gene therapy for PIDs: progress, pitfalls and prospects. Gene. 2013;525(2):174–81.
Acknowledgments
We acknowledge Alessandro Aiuti, Francisco Antonio Bonilla, Jean-Laurent Casanova, Graham Davies, Anne Durandy, Stephan Ehl, Teresa Espanol, Alain Fischer, Wilhelm Friedrich, Raif Geha, Silvia Giliani, Kimberly Gilmour, Bodo Grimbacher, Lennart Hammastom, Haifa Jabara, Alison Jones, Christine Kinnon, Anastasia Kondyli, Francoise Le Deist, Katy Mandalenaki, John Manis, M. Louise Markert, Gareth Morgan, Luigi Notarangelo, Hans Ochs, Gabriel Pantelias, Capucine Picard, Frederic Rieux-Laucat, Costas Ritis, Genevieve de Saint Basile, Fabian Schumacher, Klaus Schwarz, Antony Segal, Reinhart Seger, Edvard Smith, Christina Sobachi, Stephan Strobel, Anna Villa, Jean-Pierre de Villartay, Effie Vrachnou, David Webster, colleagues at “Aghia Sophia” and “P & A Kyriakou” Children’s Hospitals for their collaboration in many cases and for their contribution in diagnosis and/or management of certain patients, Paediatricians and Physicians from other Hospitals in Greece for referring their patients to us, as well as, nurses and technicians in our Department. We also thank 1st Health Region of Attica for supporting part of this project, Ms Penny Kassari for organizing part of this work, Mr Panos Liverakos for his encouragement, the Greek Lottery Company (Organismos Prognostikon Agonon Podosfairou - OPAP S.A) and the former President of the Board C. Hatjiemmanuil for a grant which was used for the genetic diagnosis and registry of a significant number of patients. Thanks to R. Halls for his support for the manuscript and special thanks to Mrs Pitsa Kalamotousis for her support for this project.
Author information
Authors and Affiliations
Corresponding author
Additional information
Athanasios Michos and Maria Raptaki are contributed equally
Rights and permissions
About this article
Cite this article
Michos, A., Raptaki, M., Tantou, S. et al. Primary Immunodeficiency Diseases: A 30-year Patient Registry from the Referral Center for Primary Immunodeficiencies in Greece. J Clin Immunol 34, 836–843 (2014). https://doi.org/10.1007/s10875-014-0066-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-014-0066-8